RP
Therapeutic Areas
OS Therapies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| OST-HER2 | Osteosarcoma (HER2+) | Phase 1 |
| OST-tADC Platform | Various Solid Tumors | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| OST-HER2 | Osteosarcoma (HER2+) | Phase 1 |
| OST-tADC Platform | Various Solid Tumors | Pre-clinical |